Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
98.12 CHF | -0.32% | -0.25% | +15.88% |
09-11 | NOVARTIS AG : Gets a Buy rating from UBS | ZD |
09-06 | EXECUTIVE CHANGES: Invinity replaces CEO; Gulf Keystone chair dies | AN |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
NOVARTIS AG | Other Pharmaceuticals | -0.08% | -0.25% | +15.88% | +9.50% | +13.49% | 233B |
Technical Rankings Surperformance
- Stock Market
- Equities
- NOVN Stock
- Charts Novartis AG
- Comparison Chart
MarketScreener is also available in this country: United States.
Switch edition